C.-H. Yang
Memorial Hospital of South Bend
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by C.-H. Yang.
British Journal of Dermatology | 2007
C.-H. Yang; Wu Ts; Chiu Ct
Backgroundu2002 The potentially fatal complications associated with viral hepatitis B (HBV) reactivation have not been characterized in bullous/connective tissue disease patients receiving prolonged systemic glucocorticosteroids (GCs).
British Journal of Dermatology | 2003
C.-H. Yang; Hsin-Chun Ho; Y.-S. Chan; L.-B. Liou; Hong-Shang Hong; Yang Lc
We describe a new method for treating livedoid vasculopathy. The typical presentation of livedoid vasculopathy includes chronic, recurrent painful ulcers, satellite scar‐like atrophy and telangiectasia involving the lower extremities. Histologically, these lesions show areas of ulceration and dermal vessel occlusion without frank inflammatory cell infiltration. There is currently no satisfactory therapy available for this disease. Hyperbaric oxygen (HBO) has recently established itself as one of the most effective methods of treating ischaemic wounds, including diabetic ulcers. We used this therapy in two patients whose lesions were resistant to multiple therapeutic modalities. Not only did their ulcers respond rapidly to the HBO therapy, but the disturbing wound pain also resolved at the same time. To our knowledge, this is the first successful trial of HBO therapy in livedoid vasculopathy. We believe this to be a very promising new therapy for livedoid vasculopathy and to be worth further investigation.
Journal of The European Academy of Dermatology and Venereology | 2010
Y. H. Huang; Lih-Jen Yang; Rc Y. Hui; Ya-Ching Chang; Ya-Wen Yang; C.-H. Yang; Y. H. Chen; Wen-Hung Chung; Y. Z. Kuan; Chiu Cs
Backgroundu2002 Obesity has been found to be associated with an increased risk of psoriasis in general population. However, studies addressing the relationship between obesity and clinical severity of psoriasis are still scarce, especially in Asian people.
Neurology | 2017
Chun-Bing Chen; Yi-Hsin Hsiao; Tony Wu; Mo-Song Hsih; Wichittra Tassaneeyakul; Teekayu P. Jorns; Chonlaphat Sukasem; Chien-Ning Hsu; Shih-Chi Su; Wan-Chun Chang; Rosaline Chung-Yee Hui; Chia-Yu Chu; Yi-Ju Chen; Ching‐Ying Wu; Chao-Kai Hsu; Tsu‐Man Chiu; Pei-Lun Sun; Hua-En Lee; Chin-Yi Yang; Pei-Han Kao; Chih-Hsun Yang; Hsin-Chun Ho; Jing-Yi Lin; Ya-Ching Chang; Ming-Jing Chen; Chun-Wei Lu; Chau Yee Ng; Kang-Ling Kuo; Chien-yio Lin; C.-H. Yang
Objective: To investigate the risk and genetic association of oxcarbazepine-induced cutaneous adverse reactions (OXC-cADRs), including Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN), in Asian populations (Chinese and Thai). Methods: We prospectively enrolled patients with OXC-cADRs in Taiwan and Thailand from 2006 to 2014, and analyzed the clinical course, latent period, drug dosage, organ involvement, complications, and mortality. We also investigated the carrier rate of HLA-B*15:02 and HLA-A*31:01 of patients with OXC-cADRs and compared to OXC-tolerant controls. The incidence of OXC-SJS/TEN was compared with carbamazepine (CBZ)–induced SJS/TEN according to the nationwide population dataset from the Taiwan National Health Insurance Research Database. Results: We enrolled 50 patients with OXC-cADRs, including 20 OXC-SJS/TEN and 6 u2009drug reaction with eosinophilia and systemic symptoms, of Chinese patients from Taiwan and Thai patients from Thailand. OXC-cADRs presented with less clinical severity including limited skin detachment (all ≦5%) and no mortality. There was a significant association between HLA-B*15:02 and OXC-SJS (p = 1.87 × 10−10; odds ratio 27.90; 95% confidence interval [CI] 7.84–99.23) in Chinese and this significant association was also observed in Thai patients. The positive and negative predictive values of HLA-B*15:02 for OXC-SJS/TEN were 0.73% and 99.97%, respectively. HLA-A*31:01 was not associated with OXC-cADRs. The incidence and mortality of OXC-SJS/TEN was lower than CBZ-STS/TEN in new users (p = 0.003; relative risk 0.212; 95% CI 0.077–0.584). Conclusions: Our findings suggest that HLA-B*15:02 is significantly associated with OXC-SJS in Asian populations (Chinese and Thai). However, the severity and incidence of OXC-SJS/TEN are less than that of CBZ-SJS/TEN. The need for preemptive HLA-B*15:02 screening should be evaluated further.
British Journal of Dermatology | 2014
M.-H. Chi; Rosaline Chung-Yee Hui; C.-H. Yang; J.-Y. Lin; Yu-Jr Lin; Hsin-Chun Ho; Wen-Hung Chung; Tseng-tong Kuo
Drug reaction with eosinophilia and systemic symptoms (DRESS) is a severe cutaneous adverse drug reaction. However, its histopathological features have not been well defined.
British Journal of Dermatology | 2006
Wei-Hsin Juan; Y.-S. Chan; Jennifer C. Lee; Yang Lc; Hong-Shang Hong; C.-H. Yang
Backgroundu2002 Livedoid vasculopathy, also known as atrophie blanche, is a recurrent painful vasculopathy appearing mostly on the lower limbs. Treatment is challenging and relapses are frequent.
International Journal of Clinical Practice | 2005
K.-J. Yu; Hua-En Lee; Hsin-Chun Ho; J. C. Lee; J. W.-C. Chang; Hong-Shang Hong; C.-H. Yang
Carcinoma erysipelatoides, also known as inflammatory metastatic carcinoma, is a rare form of cutaneous metastasis from a malignancy. The characteristic histopathological finding is metastatic tumour cells inside the dermal lymphatic ducts. It is frequently observed in patients with breast carcinoma as well as adenocarcinoma of pancreas, rectum, lung, ovary and parotid gland. We present a 66‐year‐old man diagnosed to have metastatic squamous cell carcinoma by aspiration cytology from an enlarged neck lymph node and a core biopsy of a left axillary mass. He subsequently received radiotherapy; however, due to intolerance to erythema and swelling on local irradiated skin, radiotherapy was deferred. Skin lesions on upper chest and neck area, consisting of erythematous induration with telangiectasia and tenderness, progressed slowly and were treated as cellulitis. The erythema remained stationary with antibiotic treatment. Skin biopsy shows poorly differentiated squamous carcinoma cells within dermis and dilated dermal vessels.
British Journal of Dermatology | 2015
Jennifer Wu; Yun-Shien Lee; Shih-Chi Su; Tsu-Lan Wu; K.C. Kao; Chiu-Ching Huang; W.C. Chang; C.-H. Yang; Wen-Hung Chung
Malignancy is known to be associated with an increased mortality rate in patients with Stevens–Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN). However, risk factors contributing to the poor prognosis of patients with SJS/TEN with malignancies remain undefined.
Medical Mycology | 2018
C.-H. Yang; Chun-Bing Chen; Yung-Yi Lee; Chih-Hsun Yang; Ya-Ching Chang; Wen-Hung Chung; Hua-En Lee; Rosaline Chung-Yee Hui; Ya-Hui Chuang; Hong-Shang Hong; Pei-Lun Sun
Chromoblastomycosis (CBM) is an implantation mycosis characterized by the presence of pigmented muriform cells in tissue. CBM is endemic in Taiwan, but only three formal cases have been reported to date because of underreporting. To describe and update its epidemiologic features, we report a series of 30 cases between 2003 and 2016 at a single medical center. Patients were predominately male (2.75:1). The mean age of onset was 65.9 years, and disease duration ranged from 2 months to 20 years. Diabetes was the most common comorbidity, and extremities were the most frequent sites of involvement. The lesions presented as papuloplaque, verrucous, cicatricial, targetoid, or mixed types. The dermoscopic features were variable, including red dots, white vague areas, black globules, and sand-like patterns. Among 10 Fonsecaea isolates further identified by sequencing the ITS regions of ribosomal DNA, nine were F. monophora and one was F. nubica. All but one patient received either systemic antifungal agents, surgical excision, or both. Surgical excision achieved a higher complete remission rate than the other forms of treatment did.
Osteoporosis International | 2013
Yun-Shien Lee; C.-H. Yang; Chiung-Mei Chen; Jawl-Shan Hwang
Strontium ranelate is an effective drug that was developed for treating osteoporosis. Here, we report the case of a 62-year-old woman who developed headache and diffuse scalp hair loss 1xa0week after receiving strontium ranelate treatment for osteoporosis. The treatment was subsequently stopped because of the intractable headache. Nevertheless, the patient continued to lose hair for 6xa0weeks following treatment discontinuation. Histopathological analysis of scalp tissues revealed anagen effluvium. The patient’s hair started regrowing slowly 2xa0months after treatment with strontium ranelate was discontinued.